Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis
Background Immune-related colitis is a common, often serious complication of immune checkpoint inhibition (ICI). Although endoscopy is not strictly recommended for any grade of diarrhea/colitis, emerging evidence suggests that endoscopic evaluation may have important therapeutic implications. In thi...
Saved in:
| Main Authors: | Melissa Lumish, Ryan J. Sullivan, Douglas B. Johnson, Michael Dougan, Anita Giobbie-Hurder, Meghan J Mooradian, Daniel Y Wang, Alexandra Coromilas, Tianqi Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/1/e000451.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis
by: Michael Dougan, et al.
Published: (2020-10-01) -
Immune checkpoint inhibitor-associated risk for venous thromboembolism: a comprehensive analysis
by: Jean M Connors, et al.
Published: (2025-05-01) -
Ulcerative colitis: focus on colonic mucosal resistance
by: M. A. Livzan, et al.
Published: (2022-04-01) -
Mucosal Barrier in Ulcerative Colitis and Crohn’s Disease
by: A. E. Dorofeyev, et al.
Published: (2013-01-01) -
Immune Checkpoint Inhibitor Use in Microscopic Colitis
by: Natalie Farha, et al.
Published: (2022-06-01)